Contraceptive Market, By Type (Combination Contraceptives, Hormonal Contraceptives, Emergency Contraceptives, By Route of Administration, By Age Group, By Distribution Channel, By Geography .

Description

Global contraceptive market was valued US$ 19.74 Bn in 2023 and is expected to reach US$ 52.41 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 13% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 19.74 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	13.00%	2030/2031 Value Projection:	US$ 52.41 Bn

Figure 1. Global Contraceptive Market Share (%), By Region, 2024

Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.

Market Dynamics:

Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.

Key Features of the Study:

This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market

Detailed Segmentation:

Global Contraceptive Market, By Type
- Combination Contraceptives
- Monophasic pills
- Multiphasic pills
- Extended-cycle pills
- Hormonal Contraceptives
- Progestin-Only Pills
- Emergency Contraceptives
- Levonorgestrel-based
- Ulipristal acetate-based
Global Contraceptive Market, By Route of Administration
- Oral
- Injectable
- Intrauterine
- Vaginal
- Others (Patches, etc.)
Global Contraceptive Market, By Age Group
- Adolescents
- Adults
Global Contraceptive Market, By Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Global Contraceptive Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Contraceptive Market:
- Bayer AG
- Pfizer Inc.
- Teva Pharmaceutical Industries
- Merck & Co.
- Janssen Pharmaceutical Companies
- Allergan
- Piramal Enterprises
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals
- Mylan Pharmaceuticals
- Mithra Pharmaceuticals
- Gedeon Richter
- HLL Lifecare
- Cadila Healthcare
- Organon
- Other Prominent Players

Product Code: CMI365

Table of Contents

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers:
Increasing popularity of contraceptive drugs
Growing government initiatives for promoting access to family planning and contraceptives
- Restraints
Side effects associated with pills
Risks of blood clots and cardiovascular diseases
- Opportunities
Growing demand in developing countries
Growing female population opting for contraceptive drugs
Key Highlights
Recent Trends
PEST Analysis
PORTER's Analysis
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations

4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Contraceptive Market, By Type, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Combination Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Monophasic pills
Multiphasic pills
Extended-cycle pills
Hormonal Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Progestin-Only Pills
Emergency Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Levonorgestrel-based
Ulipristal acetate-based

6. Global Contraceptive Market, By Route of Administration, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Intrauterine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Vaginal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Others (Patches, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

7. Global Contraceptive Market, By Age Group, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

8. Global Contraceptive Market, By Distribution Channel, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

9. Global Contraceptive Market, By Region, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 - 2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profile
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Pfizer Inc.
- Teva Pharmaceutical Industries
- Merck & Co.
- Janssen Pharmaceutical Companies
- Allergan
- Piramal Enterprises
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals
- Mylan Pharmaceuticals
- Mithra Pharmaceuticals
- Gedeon Richter
- HLL Lifecare
- Cadila Healthcare
- Organon
- Other Prominent Players
Analyst Views

11. Section

References
Research Methodology
About us